06.03.19|Hagar RavetThe second fund will focus on mid to late-stage health companies in the domains of pharma, digital health, and medical technology
04.09.17|Naomi ZoreffDespite Israel's advanced medical infrastructure, excessive red tape steers pharmaceutical companies away
27.08.17|Dror ReichThe plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus
21.08.17|Dror ReichTwo Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies